Name | Number of supported studies | Average coverage | |
---|---|---|---|
glutamatergic neuron | 12 studies | 56% ± 22% | |
oligodendrocyte precursor cell | 10 studies | 52% ± 14% | |
astrocyte | 10 studies | 35% ± 18% | |
GABAergic neuron | 5 studies | 30% ± 10% | |
neuron | 4 studies | 24% ± 7% |
Name | Number of supported studies | Average coverage | |
---|---|---|---|
brain | 10 studies | 39% ± 17% |
Tissue | GTEx Coverage | GTEx Average TPM | GTEx Number of samples | TCGA Coverage | TCGA Average TPM | TCGA Number of samples |
---|---|---|---|---|---|---|
brain | 92% | 407.92 | 2438 / 2642 | 63% | 5.05 | 446 / 705 |
prostate | 80% | 36.76 | 195 / 245 | 15% | 0.36 | 74 / 502 |
kidney | 79% | 20.42 | 70 / 89 | 4% | 0.17 | 38 / 901 |
intestine | 65% | 14.39 | 627 / 966 | 7% | 0.13 | 39 / 527 |
adrenal gland | 52% | 18.19 | 135 / 258 | 17% | 0.62 | 39 / 230 |
spleen | 54% | 8.44 | 131 / 241 | 0% | 0 | 0 / 0 |
thymus | 52% | 8.47 | 340 / 653 | 0% | 0.00 | 2 / 605 |
stomach | 40% | 8.01 | 145 / 359 | 8% | 0.14 | 23 / 286 |
blood vessel | 40% | 7.72 | 537 / 1335 | 0% | 0 | 0 / 0 |
lung | 38% | 5.59 | 222 / 578 | 1% | 0.02 | 10 / 1155 |
bladder | 33% | 10.19 | 7 / 21 | 4% | 0.15 | 22 / 504 |
peripheral blood | 35% | 8.55 | 327 / 929 | 0% | 0 | 0 / 0 |
esophagus | 30% | 4.53 | 429 / 1445 | 1% | 0.01 | 2 / 183 |
adipose | 30% | 4.33 | 362 / 1204 | 0% | 0 | 0 / 0 |
uterus | 25% | 4.29 | 43 / 170 | 2% | 0.03 | 8 / 459 |
breast | 26% | 3.37 | 118 / 459 | 0% | 0.04 | 5 / 1118 |
ovary | 15% | 2.38 | 27 / 180 | 0% | 0.00 | 1 / 430 |
heart | 13% | 1.67 | 113 / 861 | 0% | 0 | 0 / 0 |
liver | 11% | 1.39 | 25 / 226 | 0% | 0.01 | 2 / 406 |
muscle | 8% | 0.96 | 64 / 803 | 0% | 0 | 0 / 0 |
pancreas | 5% | 0.59 | 18 / 328 | 2% | 0.05 | 4 / 178 |
skin | 3% | 0.36 | 51 / 1809 | 4% | 0.11 | 18 / 472 |
abdomen | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
bone marrow | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
diaphragm | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
eye | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 80 |
gingiva | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
lymph node | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 29 |
nasal cavity | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nasopharynx | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nose | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
placenta | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
spinal column | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
tonsil | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 45 |
ureter | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 1 |
GO_0007165 | Biological process | signal transduction |
GO_0010469 | Biological process | regulation of signaling receptor activity |
GO_0014016 | Biological process | neuroblast differentiation |
GO_1902692 | Biological process | regulation of neuroblast proliferation |
GO_0005615 | Cellular component | extracellular space |
GO_0005783 | Cellular component | endoplasmic reticulum |
GO_0005515 | Molecular function | protein binding |
GO_0048018 | Molecular function | receptor ligand activity |
Gene name | TAFA1 |
Protein name | Chemokine-like protein TAFA-1 |
Synonyms | FAM19A1 |
Description | FUNCTION: Regulatory factor which is ligand for CMKLR2 and is involved in the modulation of neural stem-cell proliferation and differentiation. . |
Accessions | ENST00000496687.1 ENST00000478136.6 Q7Z5A9 |